Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could ginger and perilla replace acid pills for stomach trouble?

NCT ID NCT07655219

Symptom relief Sponsor: Liaquat University of Medical & Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a dietary supplement made from ginger and perilla (Dispepril®) can improve stomach symptoms in people with functional dyspepsia, a condition causing fullness, bloating, and pain after eating. 400 adults will be randomly assigned to take the supplement alone, the supplement plus a half-dose acid-reducing drug, or a full-dose acid-reducing drug for 14 days. The goal is to see if the supplement works as well as standard treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ginger and perilla extract supplement (Dispepril®)
What this could lead to
If it works, this could offer a natural alternative to acid-reducing drugs for people with chronic indigestion.
What could go wrong
This is a small, early-stage trial with only 14 days of treatment. The supplement may not work better than standard drugs, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female participants aged 18 to 65 years * Diagnosis of functional dyspepsia according to Rome IV criteria * Willingness and ability to provide written informed consent * Ability to follow study product administration instructions * Ability to attend scheduled study visits Exclusion Criteria: * Gastrectomy * Cancer * Use of NSAIDs, cholagogues, or tricyclic antidepressants within 30 days prior to enrollment * Helicobacter pylori positivity * Alcoholism or other substance abuse * Hepatic disease * Renal disease * History of hypersensitivity to formulation active ingredients or excipients * Pregnancy or breastfeeding * Participation in another clinical trial or completion of another clinical trial within 1 month prior to enrollment * Refusal or inability to provide informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional dyspepsia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dyspepsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Functional dysphonia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gastroenterology Centre

    Salerno, Italy

  • U.O.S.D. Digestive Endoscopy, Interventional and Emergency Unit

    Montevarchi, Italy

  • University of Rome Tor Vergata

    Rome, Italy

  • University of Urbino Carlo Bo

    Urbino, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.